Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06142006 · ClinicalTrials.gov registry record

The Diabetes Staging System in Patient Aligned Care Teams

A clinical trial of Type 2 Diabetes and Diabetes Mellitus, sponsored by Durham VA Medical Center.

Recruiting
Registry status
120
Enrollment target
1
Study location

NCT06142006 is a study of Type 2 Diabetes and Diabetes Mellitus that is actively recruiting participants, run by Durham VA Medical Center. The registered enrollment target is 120 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06142006, a study of Type 2 Diabetes and Diabetes Mellitus, is actively recruiting participants, sponsored by Durham VA Medical Center.

RECRUITING
Registry status
120 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the feasibility/acceptability of the Diabetes Staging System (DSS) in Patient Aligned Care Teams (PACT) teams and its ability to increase sodium-glucose cotransporter-2 inhibitor (SGLT2i) and glucagon-like-1 peptide (GLP-1) use in Veteran patients with type 2 diabetes and cardiovascular disease and/or chronic kidney disease.

Interventions

  • OTHER Diabetes Staging System (DSS) use among Primary Care Teams

Study Locations (1)

North Carolina

  • Greenville VA Health Care Center, 401 Moye Blvd - Greenville

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2023-09-01
Est. Completion 2025-09-01

Sponsor

Durham VA Medical Center

17 total trials

What the Registry Record Tells You About NCT06142006

The ClinicalTrials.gov registry entry for NCT06142006 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (89% lower). The listed sponsor is Durham VA Medical Center, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Diabetes Staging System (DSS) use among Primary Care Teams is the first listed.

NCT06142006 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06142006 about?

NCT06142006 is a clinical study titled "The Diabetes Staging System in Patient Aligned Care Teams". The purpose of this study is to examine the feasibility/acceptability of the Diabetes Staging System (DSS) in Patient Aligned Care Teams (PACT) teams and its ability to increase sodium-glucose cotransporter-2 inhibitor (SGLT2i) and glucagon-like-1 peptide (GLP-1) use in Veteran patients with type 2 ...

What is the current status of trial NCT06142006?

This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2023-09-01. Estimated completion is 2025-09-01.

What conditions does trial NCT06142006 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Diabetes Mellitus.

What interventions are being tested in trial NCT06142006?

The interventions under investigation include: Diabetes Staging System (DSS) use among Primary Care Teams (OTHER).

Who is sponsoring clinical trial NCT06142006?

This trial is sponsored by Durham VA Medical Center, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06142006 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.